BioCentury
ARTICLE | Company News

Lexicon Genetics Inc., Eli Lilly deal

November 20, 2000 8:00 AM UTC

LEXG granted LLY a non-exclusive license to its positive-negative selection and isogenic DNA methods of targeting genes to generate knockout mice. LLY will use the technology for internal drug discove...